Evidence map›Paper›PMID 39029090›Full record

ArticleJournal of chemical information and modeling2024

Diverse Hits in De Novo Molecule Design: Diversity-Based Comparison of Goal-Directed Generators.

Philipp Renz, Sohvi Luukkonen, Günter Klambauer

Abstract readComparative Study
In one paragraph

Article in Journal of chemical information and modeling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Test-Time Training Scaling Laws for Chemical Exploration in Drug Design.Journal of chemical information and modeling · 2025
    Article
  7. Article
  8. Generative Deep Learning for de Novo Drug Design─A Chemical Space Odyssey.Journal of chemical information and modeling · 2025
    Review
  9. Identification of nanomolar adenosine ANature communications · 2025
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Philipp RenzJohannes Kepler University Linz, Altenbergerstraße 69, Linz, AT 4040, Austria.ORCID 0000-0002-3323-7632
Sohvi LuukkonenJohannes Kepler University Linz, ELLIS Unit Linz, LIT AI Lab, Institute for Machine Learning, Altenbergerstraße 69, Linz, AT 4040, Austria.ORCID 0000-0001-9387-1427
Günter KlambauerJohannes Kepler University Linz, ELLIS Unit Linz, LIT AI Lab, Institute for Machine Learning, Altenbergerstraße 69, Linz, AT 4040, Austria.ORCID 0000-0003-2861-5552

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the rise of generative AI models, many goal-directed molecule generators have been proposed as tools for discovering novel drug candidates. However, molecule generators often produce highly similar molecules and tend to overemphasize conformity to an imperfect scoring function rather than capturing the true underlying properties sought. We rectify these two shortcomings by offering diversity-based evaluations using the #Circles metric and considering constraints on scoring function calls or computation time. Our findings highlight the superior performance of SMILES-based autoregressive models in generating diverse sets of desired molecules compared to graph-based models or genetic algorithms.

Indexed as

Drug DesignAlgorithmsArtificial IntelligenceGoals

Identifiers

PMID39029090
PMCPMC11323242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.